Medications for Major Affective Disorder 2

9 results

  • Chlorpromazine (chlorpromazine)

    (Chlorpromazine)
    Alembic Pharmaceuticals Limited
    Usage: This drug is indicated for managing symptoms of psychotic disorders, treating schizophrenia, controlling nausea and vomiting, relieving pre-surgical restlessness, managing acute intermittent porphyria, assisting in tetanus treatment, addressing manic-depressive illness, controlling intractable hiccups, and treating severe behavioral issues in children aged 1 to 12.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    A-S Medication Solutions
    Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical restlessness and apprehension, addressing acute intermittent porphyria, aiding tetanus treatment, relieving manic-depressive symptoms, addressing intractable hiccups, and treating severe behavioral issues in children aged 1 to 12.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    REMEDYREPACK INC.
    Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, easing pre-surgical restlessness, acute intermittent porphyria, tetanus adjunct treatment, manic-depressive illness symptoms, intractable hiccups, and severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine hydrochloride)
    Devatis, Inc.
    Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, relieving pre-surgery anxiety, managing acute intermittent porphyria, adjunctive treatment of tetanus, addressing manic episodes, and treating severe behavioral issues in children, including hyperactivity and conduct disorders.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    REMEDYREPACK INC.
    Usage: The drug is indicated for managing symptoms of psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical anxiety, addressing acute intermittent porphyria, aiding tetanus treatment, managing manic-depressive illness, relieving intractable hiccups, and treating severe behavioral issues in children aged 1 to 12.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (Chlorpromazine Hydrochloride)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Usage: This drug is indicated for managing psychotic disorders, treating schizophrenia, controlling nausea and vomiting, alleviating pre-surgical anxiety, and treating acute intermittent porphyria. It also aids in tetanus treatment, addresses manic-depressive illness, relieves intractable hiccups, and treats severe behavioral issues in children aged 1 to 12.

  • Chlorpromazine hydrochloride (chlorpromazine hydrochloride)

    (CHLORPROMAZINE HYDROCHLORIDE)
    Eugia US LLC
    Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, managing pre-surgical anxiety, acute intermittent porphyria, tetanus alongside other treatments, and addressing manic episodes. It also helps alleviate intractable hiccups and severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.

  • Lithium carbonate (lithium carbonate)

    (Lithium Carbonate)
    Carilion Materials Management
    Usage: Lithium carbonate is indicated for treating manic episodes of manic-depressive illness and for maintenance therapy to reduce the intensity of subsequent episodes in patients with a history of mania. It may normalize symptoms within 1 to 3 weeks in those experiencing a manic episode.

  • Lithium carbonate (lithium carbonate)

    (Lithium Carbonate)
    Rising Pharma Holdings, Inc.
    Usage: Lithium Carbonate Extended-Release Tablets are indicated for treating manic episodes of manic-depressive illness and for maintenance therapy to prevent or reduce the intensity of future episodes in patients with a history of mania. Symptomatic improvement typically occurs within 1 to 3 weeks.